Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lane Labs FTC Settlement To Fund National Cancer Institute Study

This article was originally published in The Tan Sheet

Executive Summary

Lane Labs has been ordered by the Federal Trade Commission to contribute $450,000 to fund a National Cancer Institute clinical study on the effects of shark cartilage supplementation on cancer as part of a $1 mil. settlement of charges it made unsubstantiated cancer claims for its dietary supplements.
Advertisement

Related Content

Lane Labs To Pay Consumer Restitution Under Permanent Injunction
Lane Labs To Pay Consumer Restitution Under Permanent Injunction
Lane Labs To Pay Consumer Restitution Under Permanent Injunction
Lane Labs USA
FTC Focuses On Dietary Supplement/Online Advertising In 1999
Lane Labs BeneFin Is Unapproved Drug - FDA Complaint
Lane Labs BeneFin Is Unapproved Drug - FDA Complaint
NCI Phase III Trial On Shark Cartilage May Begin Recruitment Summer/Fall

Topics

Advertisement
UsernamePublicRestriction

Register

PS091377

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel